NM_000376.3:c.-84+5133G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000376.3(VDR):​c.-84+5133G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 875,608 control chromosomes in the GnomAD database, including 43,606 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6249 hom., cov: 33)
Exomes 𝑓: 0.32 ( 37357 hom. )

Consequence

VDR
NM_000376.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.420

Publications

20 publications found
Variant links:
Genes affected
VDR (HGNC:12679): (vitamin D receptor) This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
VDR Gene-Disease associations (from GenCC):
  • vitamin D-dependent rickets, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • vitamin D-dependent rickets, type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 12-47899822-C-G is Benign according to our data. Variant chr12-47899822-C-G is described in ClinVar as Benign. ClinVar VariationId is 308889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000376.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VDR
NM_000376.3
MANE Select
c.-84+5133G>C
intron
N/ANP_000367.1
VDR
NM_001364085.2
c.-84+5133G>C
intron
N/ANP_001351014.1
VDR
NM_001017536.2
c.67+4742G>C
intron
N/ANP_001017536.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VDR
ENST00000549336.6
TSL:1 MANE Select
c.-84+5133G>C
intron
N/AENSP00000449573.2
VDR
ENST00000550325.5
TSL:1
c.67+4742G>C
intron
N/AENSP00000447173.1
VDR
ENST00000395324.6
TSL:5
c.-83-17048G>C
intron
N/AENSP00000378734.2

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40829
AN:
152036
Hom.:
6241
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.151
Gnomad AMI
AF:
0.345
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.288
Gnomad EAS
AF:
0.0200
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.403
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.344
Gnomad OTH
AF:
0.269
GnomAD4 exome
AF:
0.317
AC:
229214
AN:
723454
Hom.:
37357
Cov.:
9
AF XY:
0.318
AC XY:
107058
AN XY:
336550
show subpopulations
African (AFR)
AF:
0.131
AC:
1797
AN:
13746
American (AMR)
AF:
0.252
AC:
215
AN:
854
Ashkenazi Jewish (ASJ)
AF:
0.291
AC:
1310
AN:
4504
East Asian (EAS)
AF:
0.0233
AC:
76
AN:
3262
South Asian (SAS)
AF:
0.172
AC:
2489
AN:
14476
European-Finnish (FIN)
AF:
0.366
AC:
85
AN:
232
Middle Eastern (MID)
AF:
0.293
AC:
424
AN:
1446
European-Non Finnish (NFE)
AF:
0.327
AC:
216368
AN:
661110
Other (OTH)
AF:
0.271
AC:
6450
AN:
23824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
6557
13114
19670
26227
32784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9460
18920
28380
37840
47300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40866
AN:
152154
Hom.:
6249
Cov.:
33
AF XY:
0.269
AC XY:
19984
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.152
AC:
6300
AN:
41528
American (AMR)
AF:
0.260
AC:
3974
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.288
AC:
999
AN:
3470
East Asian (EAS)
AF:
0.0206
AC:
107
AN:
5188
South Asian (SAS)
AF:
0.177
AC:
854
AN:
4828
European-Finnish (FIN)
AF:
0.403
AC:
4263
AN:
10568
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.344
AC:
23407
AN:
67972
Other (OTH)
AF:
0.268
AC:
565
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1504
3008
4513
6017
7521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.185
Hom.:
470
Bravo
AF:
0.253
Asia WGS
AF:
0.140
AC:
488
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 25, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Vitamin D-dependent rickets type II with alopecia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.32
DANN
Benign
0.41
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11168292; hg19: chr12-48293605; API